Netanyahu Defends Israel at UN as Delegates Stage Walkout 
US Senate Rejects Iran War Powers Resolution in 50-49 Vote 
US Backs Musk in Fight Against EU’s €120 Million X Fine 
Europe Warns Russia Is Escalating Hybrid Attacks Across NATO 
Sudan Rejects US Legitimacy Remarks, Defends Sovereignty 
Yemen Violence Displaces 130,000 as Civilian Toll Rises 
US, China Extend Trade Truce to Jan. 10 Ahead of Trump-Xi Summit 
Taiwan Thanks US for Support Ahead of Trump-Xi Summit 
Gaza Faces Evacuation Crisis as War-Damaged Buildings Risk Collapse 
OpenAI Agent Breaches Australia Medicare Data Portal 
Trump, Xi Focus on Trade and AI at White House Summit 
Kremlin Says No Decision Yet on Putin-Trump December Summit 
South Korea, US Discuss Warship Building Cooperation 
Netanyahu Takes Aim at Mamdani as Israel Election Nears 
North Korea Rejects Nuclear Test Warning, Calls Nuclear Status Irreversible 
US Officials Split Over Response to Israeli West Bank Settlements 
Ghana Says Western Support Growing for Slave Trade Reparations 
Add as a preferred source on Google
The White House is reportedly considering former Deputy Surgeon General Erica Schwartz as its next nominee to lead the Centers for Disease Control and Prevention, according to a source familiar with ongoing internal discussions. Schwartz, who held senior public health responsibilities during President Donald Trump's first term, played a central role in managing the federal government's COVID-19 response, with oversight spanning national preparedness and interagency coordination.
Her potential nomination comes amid a period of significant leadership instability at the CDC. Former Director Susan Monarez was dismissed last August after publicly opposing vaccine policy changes championed by Health and Human Services Secretary Robert F. Kennedy Jr. Following Monarez's departure, HHS Deputy Secretary Jim O'Neill stepped in as acting CDC director before Jay Bhattacharya — currently heading the National Institutes of Health — assumed the role in February. O'Neill has since transitioned to lead the National Science Foundation.
Schwartz's prospective appointment has drawn early praise from notable public health figures across the political spectrum. Brett Giroir, who served as assistant secretary of health under the first Trump administration, highlighted her strong character and commitment to public service. Demetre Daskalakis, a former senior CDC immunization official who stepped down last year over vaccine policy disputes, credited Schwartz with demonstrating effective leadership throughout the pandemic and praised her work strengthening preparedness within the commissioned corps.
Washington Post reporter Dan Diamond also noted that Texas health commissioner Jen Shuford and senior FDA official Sara Brenner are being considered for other high-level CDC positions. Daskalakis suggested the three could form a capable leadership team, provided they are given the autonomy to operate independently of political interference from the HHS secretary.
No formal announcement regarding Schwartz's nomination has been made at this time.
